165 related articles for article (PubMed ID: 11584839)
1. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study.
Brandberg Y; Kock E; Oskar K; af Trampe E; Seregard S
Eye (Lond); 2000 Dec; 14(Pt 6):839-46. PubMed ID: 11584839
[TBL] [Abstract][Full Text] [Related]
2. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
[TBL] [Abstract][Full Text] [Related]
4. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
5. Depression and quality of life during treatment of ocular bulb removal in individuals with uveal melanoma.
Amaro TA; Yazigi L; Erwenne C
Eur J Cancer Care (Engl); 2010 Jul; 19(4):476-81. PubMed ID: 19912303
[TBL] [Abstract][Full Text] [Related]
6. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
7. [Cured after an intraocular tumor].
Desjardins L; Delage M; Lumbroso L; Levy C; Doz F
Bull Cancer; 2001 Nov; 88(11):1069-74. PubMed ID: 11741800
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
Augsburger JJ; Corrêa ZM; Freire J; Brady LW
Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in the follow-up of uveal melanoma patients after CyberKnife treatment.
Klingenstein A; Fürweger C; Nentwich MM; Schaller UC; Foerster PI; Wowra B; Muacevic A; Eibl KH
Melanoma Res; 2013 Dec; 23(6):481-8. PubMed ID: 24048223
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.
Klingenstein A; Fürweger C; Mühlhofer AK; Leicht SF; Schaller UC; Muacevic A; Wowra B; Hintschich C; Eibl KH
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1005-12. PubMed ID: 26573389
[TBL] [Abstract][Full Text] [Related]
13. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
Brandberg Y; Sandelin K; Erikson S; Jurell G; Liljegren A; Lindblom A; Lindén A; von Wachenfeldt A; Wickman M; Arver B
J Clin Oncol; 2008 Aug; 26(24):3943-9. PubMed ID: 18711183
[TBL] [Abstract][Full Text] [Related]
14. Phantom Eye Syndrome: Patient Experiences after Enucleation for Uveal Melanoma.
Hope-Stone L; Brown SL; Heimann H; Damato B; Salmon P
Ophthalmology; 2015 Aug; 122(8):1585-90. PubMed ID: 26004080
[TBL] [Abstract][Full Text] [Related]
15. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
16. Delays in the diagnosis of uveal melanoma and effect on treatment.
Ah-Fat FG; Damato BE
Eye (Lond); 1998; 12 ( Pt 5)():781-2. PubMed ID: 10070508
[TBL] [Abstract][Full Text] [Related]
17. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma.
Chmielowska K; Tomaszewski KA; Pogrzebielski A; Brandberg Y; Romanowska-Dixon B
Eur J Cancer Care (Engl); 2013 Jan; 22(1):88-96. PubMed ID: 22966840
[TBL] [Abstract][Full Text] [Related]
18. Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy.
Lue BH; Huang TS; Chen HJ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):28-34. PubMed ID: 17765405
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
20. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]